Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium

NCT00073710 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Secondary Hyperparathyroidism
Chronic Kidney Disease

Interventions

DRUG: Zemplar
PROCEDURE: 42 Ca carbonate absorption via single tracer method
DRUG: Calcijex

Sponsor

Abbott